Jubilant Ingrevia’s subsidiary has signed a prolific deal (USD 300 Million plus over the next few years) with an International Company. Following is the notification submitted to exchanges
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that Jubilant Agro Sciences Limited (‘JASL’), wholly owned subsidiary of the Company, has entered into an agreement with a leading Agrochemical Company (‘Customer’) to produce an Agro Intermediate for one of the key Agro actives of the Customer.
Not sure how profitable this deal is but feels like a significant one.
One thing I find confusing is that the notification (https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7e9793cb-4792-4d13-a0e7-ac792c2676af.pdf) mentions that the revenue is USD 500 Million; the company name was unclear. So I looked at the financial statement of Jubilant Agro Science Ltd. I found following info
Clearly they JASL hardly had siginifant business. And so this deal seems to be really big one for JASL (and so far Jubilant Ingrevia).
Thanks,
Krishna
| Subscribe To Our Free Newsletter |
